Peptidoglycan fragments (PGN fragments)

Peptidoglycan fragments, often referred to as muropeptides, are degradation products of the bacterial cell wall that act as critical signaling molecules in the host-pathogen interface. These fragments are primarily recognized by the intracellular pattern recognition receptors NOD1 and NOD2, which detect specific motifs like meso-diaminopimelic acid and muramyl dipeptide, respectively (Philpott et al., 2014). Upon binding, these receptors initiate signaling cascades involving the RIP2 kinase, ultimately leading to the activation of NF-kappaB and the production of pro-inflammatory cytokines (Wolf & Cassel, 2010). In therapeutic applications, synthetic analogs of these fragments, such as mifamurtide, are employed as immunomodulators to stimulate the innate immune system against residual cancer cells in osteosarcoma (Meyers et al., 2008). Conversely, the over-activation or dysregulation of peptidoglycan sensing is implicated in the pathogenesis of inflammatory bowel diseases, such as Crohn's disease, where mutations in the NOD2 receptor alter the host's ability to manage intestinal microbiota (Hugot et al., 2001). Understanding the structural diversity and receptor specificity of these fragments is essential for developing targeted anti-inflammatory therapies and more effective vaccine adjuvants.

Other names

MuropeptidesMuramyl dipeptideMDPTracheal cytotoxinTCTPeptidoglycan-derived muropeptides

Activation of intracellular pattern recognition receptors NOD1 and NOD2, leading to the induction of pro-inflammatory signaling pathways such as NF-kappaB and MAPK.